3-methylglutaconic acid has been researched along with Autosomal Dominant Optic Atrophy in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boulton, ME; Brownstein, DG; Davies, JR; Davies, VJ; Hogan, V; Hollins, AJ; Moat, SJ; Nichols, PP; Piechota, M; Powell, KA; Votruba, M; White, KE; Wride, MA; Yip, W | 1 |
1 other study(ies) available for 3-methylglutaconic acid and Autosomal Dominant Optic Atrophy
| Article | Year |
|---|---|
A missense mutation in the murine Opa3 gene models human Costeff syndrome.
Topics: Amino Acid Metabolism, Inborn Errors; Amino Acid Sequence; Animals; Base Sequence; Brain; Cardiomyopathy, Dilated; Disease Models, Animal; Glutarates; Humans; Mice; Mice, Inbred C3H; Molecular Sequence Data; Mutation, Missense; Optic Atrophy, Autosomal Dominant; Optic Nerve; Phenotype; Point Mutation; Proteins; Retinal Ganglion Cells; Reverse Transcriptase Polymerase Chain Reaction; Spinal Cord; Syndrome; Transcription, Genetic; Visual Acuity | 2008 |